Recordati Industria Chimica e Farmaceutica SpA 2024 AR2
The report highlights Recordati's outstanding performance in 2024, achieving a double-digit revenue growth of 12.4% to reach €2,341.6 million and an EBITDA increase of 12.5% to €865.8 million. The company expanded its rare diseases portfolio with the acquisition of the global rights to Enjaymo® from Sanofi. On the sustainability front, Recordati completed the installation of solar panels in Türkiye, reaching an installed capacity of approximately 860 kWp, and conducted 59 supplier ESG audits. Additionally, the company endorsed the European Diversity Charters in 13 EU countries and supported around 1,600 rare-disease patients through dedicated access programs.
Company: Recordati Industria Chimica e Farmaceutica SpA
Sector: Health Care
Country: Italy
Year: 2024
Type: AR2
Pages: 332
Recordati Industria Chimica e Farmaceutica SpA
Annual Report
The report highlights Recordati's outstanding performance in 2024, achieving a double-digit revenue growth of 12.4% to reach €2,341.6 million and an EBITDA increase of 12.5% to €865.8 million. The company expanded its rare diseases portfolio with the acquisition of the global rights to Enjaymo® from Sanofi. On the sustainability front, Recordati completed the installation of solar panels in Türkiye, reaching an installed capacity of approximately 860 kWp, and conducted 59 supplier ESG audits. Additionally, the company endorsed the European Diversity Charters in 13 EU countries and supported around 1,600 rare-disease patients through dedicated access programs.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees